# pharmaceutical-challenge
The Pymaceuticals.ipynb reviews the Pymaceuticals, Ic company study on squamous cell carcinoma (SCC).  The study observes tumor development over 45 days.  
The Pymaceuticals.ipynb provides statistical analysis on how effective the drugs were to address SCC for each mouse.
The information analyzes the effectiveness of the drug based on the mouse, gender and timepoints of the study.
